A detailed history of Zeke Capital Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 9,073 shares of BSX stock, worth $789,260. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,073
Previous 9,074 0.01%
Holding current value
$789,260
Previous $351,000 19.37%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $39 - $47
-1 Reduced 0.01%
9,073 $419,000
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $4,515 - $13,488
-123 Reduced 1.34%
9,074 $351,000
Q2 2022

Aug 09, 2022

SELL
$35.24 - $47.1 $2,960 - $3,956
-84 Reduced 0.91%
9,197 $343,000
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $379,592 - $418,573
9,281 New
9,281 $411,000
Q1 2020

Apr 24, 2020

SELL
$25.83 - $45.71 $500,714 - $886,088
-19,385 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$37.87 - $45.37 $14,958 - $17,921
-395 Reduced 2.0%
19,385 $877,000
Q3 2019

Oct 18, 2019

BUY
$40.31 - $43.45 $48,372 - $52,140
1,200 Added 6.46%
19,780 $805,000
Q2 2019

Jul 24, 2019

SELL
$34.91 - $42.98 $77,884 - $95,888
-2,231 Reduced 10.72%
18,580 $799,000
Q1 2019

Apr 29, 2019

SELL
$32.91 - $40.75 $38,175 - $47,270
-1,160 Reduced 5.28%
20,811 $799,000
Q4 2018

Feb 11, 2019

SELL
$31.73 - $39.04 $148,179 - $182,316
-4,670 Reduced 17.53%
21,971 $776,000
Q2 2018

Jul 24, 2018

BUY
$26.84 - $34.32 $16,077 - $20,557
599 Added 2.3%
26,641 $871,000
Q1 2018

May 03, 2018

BUY
$25.2 - $28.54 $397,000 - $449,619
15,754 Added 153.13%
26,042 $711,000
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $461,936 - $555,293
-18,634 Reduced 64.43%
10,288 $255,000
Q3 2017

Nov 09, 2017

BUY
$26.26 - $29.17 $759,491 - $843,654
28,922
28,922 $844,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.